Related Articles

• [Retracted] MiR‑132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3
• [Retracted] miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
• [Retracted] Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
• [Retracted] miR‑133a inhibits cervical cancer growth by targeting EGFR
• [Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression